A VESICULAR DRUG DELIVERY FOR FUTURISTIC DRUG DELIVERY APPLICATIONS: UFASOMES

Article Sidebar

PDF
Published Apr 4, 2023
DOI https://doi.org/10.30750/ijpbr.10.4.01

Main Article Content

HARSHIL PATEL
Associate Professor

Abstract

In vesicular drug delivery devices, aqueous cubicles are covered by one or more concentric bilayers comprised of amphiphilic molecules. Due to their ability to localise drug exercise to the website online or organ of action, they are an incredible distribution strategy for focused medicine transport. The vesicular drug delivery method keeps the drug motion moving at a steady pace. The body's opioid frequency is thereafter maintained while the negative side effects are diminished. Vesicles made of unsaturated fatty acids are known as ufasomes. They are closed lipid bilayer suspensions of fatty acids and their ionised species that have their pH regulated. Fatty acid vesicles are regularly produced by the lipid movie hydration system. Oleic acid is the fatty acid that produces ufasomes most frequently. Unsaturated fatty acid vesicles are suspensions of fatty acid-based closed lipid bilayers, with the pH range in which their ionised species can exist being between 7 and 9. Recent developments might make it possible to create ufasomes with customizable properties such a wider pH range, resistance to divalent cations, and greater stability.

Article Details

How to Cite
1.
PATEL H. A VESICULAR DRUG DELIVERY FOR FUTURISTIC DRUG DELIVERY APPLICATIONS: UFASOMES. IJPBR [Internet]. 4Apr.2023 [cited 21Jun.2025];10(04). Available from: https://ijpbr.in/index.php/IJPBR/article/view/1040
Issue
Vol 10 No 04 (2022): Indian Journal of Pharmaceutical and Biological Research
Section
Review Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

References

1. Patel DM, Jani RH, Patel CN. Ufasomes: A Vesicular Drug Delivery. Syst Rev Pharm, 2011; 2(2): 72-8.
2. Madhukar Shende & Satish Bodele., Ufasomes: An Emerging Vesicular System For Futuristic Drug Delivery Applications. World Journal Of Pharmaceutical And Medical Research, 2021,7(11), 217 – 223
3. Kumar P, Singh SK. Oleic acid nanovesicles of minoxidil for enhanced follicular delivery. Medicines, 2018; 5(3): 103.
4. Meraz CA, Rodriguez VA. Clotrimazole Loaded Ufosomes for Topical Delivery: Formulation Development and In-Vitro Studies. Molecules, 2019; 24(17): 3139.
5. Lakshmi VS, Manohar RD, Mathan S, Dharan SS. Ufasomes: A Potential Vesicular Carrier System. J Pharm Sci Res, 2020; 12(10): 1332-5.
6. Kumar L, Verma S. Fatty acid vesicles acting as expanding horizon for transdermal delivery. Artif Nanomed Biotechnol, 2017; 45(2): 251-60.
7. Salama AH, Aburahma MH. Ufasomes nano-vesicles-based lyophilized platforms for intranasal delivery of cinnarizine: preparation, optimization, ex-vivo histopathological safety assessment and mucosal confocal imaging. Pharm Dev Technol, 2015; 21(6): 706-15.
8. Nair AJ, George A. Ufasome: A potential phospholipid as a novel pharmaceutical formulation. Int Res J Pharm, 2014; 5(4): 250-3.
9. Jain S, Jain V, Mahajan SC. Lipid based vesicular drug delivery system. Adv Pharm, 2014; 2014: 1-12.
10. Patel SA. Review on ufasomes and vesicular drug delivery system. Pharm Res, 2013; 9(1): 32-43.
11. Verma S, Bhardwaj A. Oleic acid vesicles: a new approach for topical delivery of antifungal agent. Artif Nanomed Biotechnol, 2013; 42(2): 95-101.
12. Rajalakshmi R, Aiswarya R, Kumar AR, Kumar SS, Nair SC. Ufasomes: Unsaturated Fatty Acid Based Vesicular Drug Delivery System. Int J Appl Pharm, 2021; 13(2): 76-83.